Tenx Keane Acquisition CTOR 深 沪
等待开盘 05-12 09:30:00 美东时间
0.8959
-0.011
-1.20%
华盛通- 最 高0.9834
- 今 开0.88
- 成交量 4.84万股
- 最 低 0.8712
- 昨 收 0.9068
- 总市值 0
- 52周最高 6.19
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.4912
- 委 比 -98.10%
- 总股本 --
- 历史最高 49.00
- 量 比 0
- 振 幅 12.37%
- 历史最低 0.00
- 每 手 1
- 风险率 0.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Breakdown: Citius Oncology Q1
Citius Oncology (NASDAQ:CTOR) reported its Q1 earnings results on Friday, Febru...
02-13 21:24
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why
Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPHIR therapy and a fiscal 2025 business update.
2025-12-24 14:56
Citius Oncology Q4 EPS $(0.06), Inline
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 57.14 percent increase over losses of $(0.14) per share from the same period last year.
2025-12-24 05:39
【华鑫电子通信|行业周报】第二届湾芯展成功举办，ASML、台积电Q3业绩大增
（来源：华鑫研究） ▌ 上周回顾 10月13日-10月17日当周，申万一级行业涨跌呈分化的态势。其中电子行业下跌7.14%，位列第31位。估值前三...
2025-10-21 11:00
2025中国汽车芯片优秀供应商奖闪耀公布！国产芯的华丽蝶变，点燃汽车未来之光
在全球汽车工业的璀璨长河中，中国电动汽车产业的崛起如一颗耀眼的彗星，划破夜空，照亮了整个行业。我们不仅仅是销量的王者——中国已稳稳占据全球电动车销量宝座，成为无...
2025-10-17 07:15
银诺医药-B(02591)暗盘暴涨270%引市场聚焦GLP-1赛道，派格生物医药-B(02565)价值洼地增长可期
近年来，全球胰高血糖素样肽-1受体激动剂(GLP-1)类药物市场持续扩容，2024年GLP-1药物强势登顶全球药品销售榜，销售收入超500亿美元;2025年仅...
2025-08-14 23:19
Dr. Reddy's Laboratories Agreed To Partially Defer A Milestone Payment From Citius Oncology, Inc., Due On September 9, 2024, Upon FDA Approval Of LYMPHIR, Without Penalty, Pending Further Discussions, As Per Their 2021 Asset Purchase Agreement
Pending further discussions with Dr. Reddy's Laboratories SA, a subsidiary of Dr. Reddy's Laboratories, Ltd. (collectively, "Dr. Reddy's"), Dr. Reddy's agreed to a partial deferral without penalty of a milestone payment
2024-09-13 20:40
